This multi-center randomized trial (MCRT) will investigate the effectiveness of the VestAid application to provide equivalent or faster recovery from dizziness compared to standard-of-care delivery of vestibular rehabilitation exercises.
Snellen visual acuity (corrected) greater than 20/40
No more than 25dB hearing loss at 500,1000, 2000, and 4000 Hz
Ability to detect 4.31 using Semmes-Weinstein monofilament at the lower extremity
At least 40 degrees of neck yaw motion with only mild to moderate pain (6 or under on 0-10 numeric pain scale)
Greater then 30 days since diagnosis of concussion/mTBI or inner ear problem
No access to internet at home
Younger than 18 years of age or older than 60 years of age
Cannot read or understand English
Parallel
Vestibular Rehabilitation Aid
DeviceThe tablet-based VestAid system was developed to repair, restore and maintain vestibular-ocular function that is impaired in patients post-mTBI. Each participant\'s treating physical therapist will develop their own personalized exercise prescription. The physical therapist will be asked to recommend that the patients complete a home exercise program at least 2-3 times per day for 6 weeks. The exercise prescription will be placed on the VestAid by the physical therapist for the patient to follow. The patient is not able to modify the exercise, only the physical therapist can modify the exercises. Exercises will be modified based on patient\'s response and symptom reports. The physical therapist and study coordinator will receive an alert on the VestAid online dashboard if the patient\'s symptoms are greater than or equal to 8/10.
Standard of care vestibular rehabilitation
Other interventionVestibular rehabilitation to include gaze stabilization exercises, optokinetic training, smooth pursuits and saccades
Dizziness Handicap Inventory (DHI)
A self report measure of dizziness (questionnaire)
Secondary Endpoint
Subjective symptom reporting of dizziness, headache, nausea, and fogginess
Click on the lead sponsor to view all of their trials.
BlueHalo
Lead sponsor
University of Pittsburgh
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
